Looks like you clickedhttps://cllsociety.org/2020/08/asco-2020-top-12-1-fixed-duration-venetoclax-obinutuzumab-for-previously-untreated-patients-with-chronic-lymphocytic-leukemia-follow-up-of-efficacy-and-safety-results-from-the-multicenter-open/?fbclid=IwAR2fgndiFnIuJITu61raWOq4w4-m5rzQ0x8Kz3-UPfootTlNWRQS8tV3r5A
If you do not want to visit that page, you can close this browser tab.
